Lydon Nicholas

CIK 00016399352 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001639935

Recent Transactions

50 trades

Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-06-12+4,570→ 4,570 total
Award
Blueprint Medicines Corp
Common Stock
2024-06-12+2,242→ 58,026 total
Award
Blueprint Medicines Corp
Common Stock
2023-06-21+2,600→ 55,784 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2023-06-21+5,300→ 5,300 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2022-06-21+5,300→ 5,300 total
Award
Blueprint Medicines Corp
Common Stock
2022-06-21+2,600→ 53,184 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2022-05-23−10,909→ 0 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2022-05-23$19.53/sh+10,909→ 50,584 total
Award
Blueprint Medicines Corp
Common Stock
2021-06-02+2,250→ 39,675 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2021-06-02+4,500→ 4,500 total
Sale
Blueprint Medicines Corp
Common Stock
2020-10-01$93.68/sh−3,896→ 43,344 total
Sale
Blueprint Medicines Corp
Common Stock
2020-10-01$92.88/sh−4,530→ 38,814 total
Sale
Blueprint Medicines Corp
Common Stock
2020-10-01$92.06/sh−1,389→ 37,425 total
Sale
Blueprint Medicines Corp
Common Stock
2020-09-17$80.00/sh−500→ 47,240 total
Sale
Blueprint Medicines Corp
Common Stock
2020-07-06$80.44/sh−25,407→ 48,340 total
Sale
Blueprint Medicines Corp
Common Stock
2020-07-06$81.02/sh−600→ 47,740 total
Sale
Blueprint Medicines Corp
Common Stock
2020-07-02$80.13/sh−2,825→ 73,747 total
Sale
Blueprint Medicines Corp
Common Stock
2020-07-01$80.21/sh−1,300→ 76,572 total
Award
Blueprint Medicines Corp
Common Stock
2020-06-24+2,250→ 77,872 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2020-06-24+4,500→ 4,500 total
Sale
Blueprint Medicines Corp
Common Stock
2020-06-23$80.00/sh−400→ 75,622 total
Sale
Blueprint Medicines Corp
Common Stock
2020-06-22$80.29/sh−13,017→ 76,022 total
Exercise/Conversion
Blueprint Medicines Corp
Restricted Stock Units
2020-06-19−1,312→ 0 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2020-06-19+1,312→ 89,039 total
Gift
Blueprint Medicines Corp
Common Stock
2020-05-15−20,000→ 87,727 total
Gift
Blueprint Medicines Corp
Common Stock
2019-08-19−20,000→ 107,727 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2019-06-19+4,875→ 4,875 total
Award
Blueprint Medicines Corp
Restricted Stock Units
2019-06-19+1,312→ 1,312 total
Sale
Blueprint Medicines Corp
Common Stock
2019-06-13$90.36/sh−25,000→ 127,727 total
Sale
Blueprint Medicines Corp
Common Stock
2019-06-12$84.66/sh−6,300→ 160,227 total
Sale
Blueprint Medicines Corp
Common Stock
2019-06-12$83.83/sh−5,200→ 155,027 total
Sale
Blueprint Medicines Corp
Common Stock
2019-06-12$82.45/sh−2,000→ 153,027 total
Sale
Blueprint Medicines Corp
Common Stock
2019-06-12$85.75/sh−11,200→ 166,527 total
Sale
Blueprint Medicines Corp
Common Stock
2019-06-12$81.96/sh−300→ 152,727 total
Award
ANAPTYSBIO, INC$ANAB
Director Stock Option (Right to Buy)
2019-02-08+6,000→ 6,000 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2018-06-21+7,500→ 29,318 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2018-04-16$88.30/sh−4,250→ 276,131 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2018-04-16$84.18/sh−2,600→ 301,506 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2018-04-16$87.46/sh−9,425→ 280,381 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2018-04-16$90.26/sh−2,222→ 271,106 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2018-04-16$89.42/sh−2,803→ 273,328 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2018-04-16$86.15/sh−1,390→ 289,806 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2018-04-16$85.11/sh−10,310→ 291,196 total
Sale
Blueprint Medicines Corp
Common Stock
2018-02-28$88.20/sh−5,264→ 187,867 total
Sale
Blueprint Medicines Corp
Common Stock
2018-02-28$89.03/sh−9,596→ 193,131 total
Sale
Blueprint Medicines Corp
Common Stock
2018-02-28$86.92/sh−5,527→ 182,340 total
Sale
Blueprint Medicines Corp
Common Stock
2018-02-28$86.35/sh−4,613→ 177,727 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2018-02-15$4.55/sh+16,483→ 304,106 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Series C Preferred Stock Warrant (right to buy)
2018-02-15−16,483→ 0 total
Award
ANAPTYSBIO, INC$ANAB
Director Stock Option (right to buy)
2018-02-02+6,000→ 6,000 total

Companies

Recent Filings

Address

C/O BLUEPRINT MEDICINES CORPORATION, 215 FIRST STREET

CAMBRIDGE, MA, 02142

View on SEC.gov